ILC Therapeutics has discovered two separate novel treatments for Covid-19 patients before they are put on ventilators. The UK-based firm is now urgently seeking funding of £4 million to accelerate safety studies and clinical trials.   ILC Therapeutics has patented a new Interferon-Alpha subtype, called Interferon Alpha 14, which can be administered to patients through injection or inhalation. This natural human molecule treatment could prevent Covid-19 induced Acute Respiratory Distress Syndrom...